| 摘要 |
The invention refers to medicine, namely to the infectious diseases. Summary of the invention consists in that treatment of acute viral hepatitis C includes the symptomatic therapy and additional administration of the immunomodulatory and antiviral remedy 5alpha-furostan-3 beta,22,26-triol-3[O- beta - galactopyranosyl(1-->2)-beta-D-glucopyranosyl)(1-->4)-beta-D-galactopyranosyl]-26-O-beta-D-glucopyranoside (pacovirin) during 10 days, beginning with the first day of clinical manifestation or hospitalization, for 50 mg, 3 times a day, per os.
|
